Development and validation of a nomogram to predict poor efficacy of imatinib in the treatment of newly diagnosed chronic phase chronic myeloid leukemia patients

Development and validation of a nomogram to predict poor efficacy of imatinib in the treatment of newly diagnosed chronic phase chronic myeloid leukemia patients

BackgroundImatinib is the most widely used tyrosine kinase inhibitor (TKI) in patients with newly diagnosed chronic-phase chronic myeloid leukemia(CML-CP). However, failure to achieve optimal response after imatinib administration, and subsequent switch to second-generation TKI therapy results in po...

全面介绍

书目详细资料
Main Authors: Yuxin Li, Yilin Zhang, Jin Wang, Aili He, Wanggang Zhang, Xingmei Cao, Yinxia Chen, Jie Liu, Pengyu Zhang, Jianli Wang, Wanhong Zhao, Yun Yang, Xin Meng, Sheping Chen, Longjin Zhang, Ting Wang, Xugeng Wang, Xiaorong Ma
格式: 文件
语言:English
出版: Frontiers Media S.A. 2024-06-01
丛编:Frontiers in Oncology
主题:
chronic phase chronic myeloid leukemia
imatinib
prognostic model
nomogram
Sokal score
Euro score
在线阅读:https://www.frontiersin.org/articles/10.3389/fonc.2024.1418417/full

因特网

https://www.frontiersin.org/articles/10.3389/fonc.2024.1418417/full

相似书籍